← Open Payments lookup

ABIGAIL CHEKENYERE: Open Payments

NPI 1457938573 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$355 in 4 payments from 3 companies in 2025. Trend: 2023 $126 · 2024 $169 · 2025 $355

Food & beverage: $355
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.1$139
E.R. Squibb & Sons, L.L.C.1$110
Otsuka America Pharmaceutical, Inc.2$107

Products named: INGREZZA, COBENFY, ABILIFY MAINTENA, REXULTI.

Industry payments across TX — which companies pay providers there.